Tedizolid - Merck & Co
At a glance
- Drug Originator Dong-A Pharmaceutical
- Drug Licenced by Merck & Co; Nabriva Therapeutics
- Drug Class Anti-infectives; Antibacterials; Fluorinated hydrocarbons; Oxazolidinones; Phosphates; Pyridines; Small molecules; Sodium compounds; Tetrazoles
- Mechanism of Action Ribosomal protein inhibitors
- USA Patent Applicants CUBIST PHARMS LLC
- USA Patents 8
- NDAs 2
- International Patents 78
- Patent Applications 88
Table of Contents
Disclaimer